1292PALK INHIBITOR AP26113 IN PATIENTS WITH ADVANCED MALIGNANCIES, INCLUDING ALK+ NON-SMALL CELL LUNG CANCER (NSCLC): UPDATED EFFICACY AND SAFETY DATA.
暂无分享，去创建一个
T. Clackson | A. Shaw | S. Gettinger | R. Camidge | R. Salgia | G. Weiss | F. Haluska | R. Rosell | L. Bazhenova | C. Langer | V. Rivera | K. Gold | D. Dorer | N. Narasimhan